Literature DB >> 15227172

Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins.

D Kalman1, S L Barriere.   

Abstract

Entities:  

Year:  1990        PMID： 15227172      PMCID： PMC324918     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  89 in total

1.  Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.

Authors:  B L Wasilauskas
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Jan-Feb       Impact factor: 2.803

2.  Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.

Authors:  K E Aldridge
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Jan-Feb       Impact factor: 2.803

Review 3.  Cephalosporins.

Authors:  M G Martens
Journal:  Obstet Gynecol Clin North Am       Date:  1989-06       Impact factor: 2.844

Review 4.  Nephrotoxicity of aminoglycosides and cephalosporins in combination.

Authors:  G O Rankin; C H Sutherland
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1989

5.  A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.

Authors:  A Iravani; G A Richard; D Johnson; A Bryant
Journal:  Am J Med       Date:  1988-09-16       Impact factor: 4.965

Review 6.  Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.

Authors:  R Kiani; D Johnson; B Nelson
Journal:  Am J Med       Date:  1988-09-16       Impact factor: 4.965

7.  A randomized prospective study of antibiotic prophylaxis during abdominal surgery.

Authors:  H V Gaskill; B A Levine
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

8.  Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.

Authors:  L S Welage; L G Hejmanowski; J H Wilton; C Walawander; D Rigan; J S Williams; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

9.  Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis.

Authors:  B Schwartz; A Al-Tobaiqi; A Al-Ruwais; R E Fontaine; J A'ashi; A W Hightower; C V Broome; S I Music
Journal:  Lancet       Date:  1988-06-04       Impact factor: 79.321

Review 10.  Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.

Authors:  R N Brogden; D M Campoli-Richards
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546
View more
  8 in total

1.  An audit of prophylactic surgical antibiotic use in a Sudanese Teaching Hospital.

Authors:  Abubaker Ibrahim Elbur; Mirghani Abd El Rahman Yousif; Ahmed Sayed Ahmed Elsayed; Manar Elsheikh Abdel-Rahman
Journal:  Int J Clin Pharm       Date:  2012-11-08

2.  Prophylactic antibiotics and wound infection.

Authors:  Abubaker Ibrahim Elbur; Yousif M A; Ahmed S A El-Sayed; Manar E Abdel-Rahman
Journal:  J Clin Diagn Res       Date:  2013-12-15

Review 3.  Small Molecule Sensors Targeting the Bacterial Cell Wall.

Authors:  Matthew F L Parker; Robert R Flavell; Justin M Luu; Oren S Rosenberg; Michael A Ohliger; David M Wilson
Journal:  ACS Infect Dis       Date:  2020-06-09       Impact factor: 5.084

Review 4.  Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use.

Authors:  E Strehl; F Kees
Journal:  Drugs       Date:  2000       Impact factor: 9.546

5.  Clinical effectiveness of beta-lactams versus fluoroquinolones as empirical therapy in patients with diabetes mellitus hospitalized for urinary tract infections: A retrospective cohort study.

Authors:  Yu-Hsin Tang; Po-Liang Lu; Ho-Yin Huang; Ying-Chi Lin
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

6.  Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.

Authors:  Paul Skorup; Lisa Maudsdotter; Miklós Lipcsey; Markus Castegren; Anders Larsson; Ann-Beth Jonsson; Jan Sjölin
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

Review 7.  Role of cephalosporins in the era of Clostridium difficile infection.

Authors:  Mark H Wilcox; James D Chalmers; Carl E Nord; Jane Freeman; Emilio Bouza
Journal:  J Antimicrob Chemother       Date:  2016-09-22       Impact factor: 5.790

8.  Antibiotic-induced microbiome perturbations are associated with significant alterations to colonic mucosal immunity in rhesus macaques.

Authors:  Jennifer A Manuzak; Alexander S Zevin; Ryan Cheu; Brian Richardson; Jacob Modesitt; Tiffany Hensley-McBain; Charlene Miller; Andrew T Gustin; Ernesto Coronado; Toni Gott; Mike Fang; Michael Cartwright; Solomon Wangari; Brian Agricola; Drew May; Elise Smith; Hans Benjamin Hampel; Michael Gale; Cheryl M Cameron; Mark J Cameron; Jeremy Smedley; Nichole R Klatt
Journal:  Mucosal Immunol       Date:  2019-12-04       Impact factor: 7.313
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.